What does Corcept Therapeutics Incorporated do?
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to…
What is Corcept Therapeutics Incorporated's P/E and P/B ratio?
Corcept Therapeutics Incorporated has a P/E ratio of 238.9 and a P/B ratio of 16.46.
What is Corcept Therapeutics Incorporated's debt-to-equity ratio?
Corcept Therapeutics Incorporated has a debt-to-equity ratio of 0.01.
How much does Corcept Therapeutics Incorporated owe compared with what it owns?
Corcept Therapeutics Incorporated owes $0.21 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Corcept Therapeutics Incorporated's Positivity rank?
Corcept Therapeutics Incorporated is ranked #5,945 of 6,775 companies globally and #3,338 of 4,000 in United States on PositoAI, with a Positivity Score of 13,721.
Does Corcept Therapeutics Incorporated have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Corcept Therapeutics Incorporated.
Where can I read the latest news about Corcept Therapeutics Incorporated?
Recent headlines about Corcept Therapeutics Incorporated from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Corcept Therapeutics Incorporated have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Corcept Therapeutics Incorporated's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.